Serum Levels of Vascular Endothelial Growth Factor Dependent on the Stage Progression of Lung Cancer
- 1 October 2000
- Vol. 118 (4) , 948-951
- https://doi.org/10.1378/chest.118.4.948
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cellsPublished by Elsevier ,2004
- Vascular endothelial growth factor (VEGF) in inflammatory and malignant pleural effusionsThorax, 1999
- Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptorsProceedings of the National Academy of Sciences, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsProceedings of the National Academy of Sciences, 1997
- Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinomaBritish Journal of Cancer, 1996
- Evaluating Prethrombotic State In Lung Cancer Using Molecular MarkersChest, 1993
- Hypoxic pulmonary vasoconstriction in the adult respiratory distress syndromeActa Anaesthesiologica Scandinavica, 1991
- Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levelsThrombosis Research, 1990
- Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.Journal of Clinical Investigation, 1981